Patent Application
20130108738
The present invention relates to phytases, to amino acid sequences coding for phytase enzymes and to nucleotide sequences which code for phytases, and to processes for the preparation and the use of phytases and to animal feeds comprising these phytases.
Phosphorus is an essential element for the growth of living organisms. In animal production, feed, as a rule, has to be supplemented with inorganic phosphorus in order to achieve good growth rates. In cereals and pulses, phosphorus is stored mainly in the form of phytate. However, monogastric animals such as pigs, poultry and fish are not capable of directly absorbing phytate or phytic acid, which results in the excretion of phytate, which means phosphorus overloads in regions with intensive livestock production. Furthermore, phytic acid, which binds metals such as calcium, copper or zinc, acts as a substance with a negative effect on the metabolism of monogastric animals. In order to compensate for the phosphate deficit of these animals and to ensure sufficient growth and sufficient health, inorganic phosphate is added to the animal feed. This addition of inorganic phosphate is costly and leads to a further adverse effect on the environment. By using a phytase in animal feeds, the phytate is hydrolyzed and results in a lower content of inositol phosphate and inorganic phosphates in the slurry. The addition of phytases to animal feeds improves the availability of organic phosphorus and reduces the adverse effect on the environment by excreted, phytate-bound phosphates. The literature describes a variety of natural phytases, both of fungal and of bacterial origin.
Phytases, also referred to as myo-inositol hexakisphosphate phosphohydrolase, are a class of phosphatases which are capable of cleaving at least one phosphate residue from phytate.
EP 420 358 generally describes the cloning and expression of microbial phytases, WO 2006/38062 describes microbial phytases derived from Citrobacter freundii as additive to animal feeds, and WO 2007/112739 describes phytases based on a natural phytase from Citrobacter braakii and processes for its preparation and the use in animal feeds.
Haefner et al. (Haefner S., Knietsch A., Scholten E., Braun J., Lohscheidt M. and Zelder O. (2005) Biotechnological production and application of phytases. Appl Microbiol Biotechnol 68:588-597) describe a multiplicity of known uses of phytases in the field of human or animal nutrition. Further uses of phytases such as, for example, the use for hydrolyzing biomass or starch in the production of bioethanol are described in WO 2008/097620.
WO 2008/116878 and WO 2010/034835 describe a phytase from Hafnia alvei, its protein sequence and variants thereof. Zinin et al. (FEMS Microbiology Letters (2004) 236:283-290) disclose a phytase from Obesumbacterium proteus, whose sequence is deposited at the UNIPROT database with the accession number Q6U677. The patent applications WO 2006/043178, WO 2008/097619 and WO 2008/092901 describe phytases from various Buttiauxella sp. The natural phytases with the currently highest specific activities include the natural phytases from Yersinia intermedia (WO 2007/128160) and Yersinia pestis (WO 02/048332).
However, all of these currently available phytases do not show those properties which are required for the preparation of animal feed additives. The currently available phytases are not sufficiently thermally stable for being employed in the preparation of animal feed pellets without a considerable loss of their activity. In the preparation of animal feed pellets, phytase together with further customary animal feed components is compressed under high temperatures and humidity in order to be fed to the livestock as one entity. An effective destruction of salmonella sp. and the gelatinization of the starch is only achieved above a temperature of 80° C. during the preparation (Amerah et al. Worlds Poulty Science Journal (2011) 67:29-45). This compressing under hot and humid conditions results in considerable phytase activity losses. One possibility of preventing this loss of activity is the laborious coating of the phytase particles, so that they are protected against the effect of heat. This coating of the phytase additions causes considerable additional costs as the result of the fats or polymers employed for the coating. The doses of commercial phytases are usually determined on the basis of the activity determination at pH 5.5 (DIN ISO 30024:2009) and is not adapted to match the pH in the respective digestive tract. This results in considerable misdosages by variation of the activity at pH values other than 5.5.
It was therefore an object of the present invention to provide a phytase which has a sufficient thermal stability, so that it can be employed in the preparation of salmonella-free feed pellets without additional protective measures such as coating and with activity losses which are as low as possible. It was a further object of the invention to provide a phytase which can be employed over a wide pH range accompanied by as little reduction of the enzymatic activity as possible, so that it can be employed in the various pH ranges of the digestive tracts of different animal species and so that a sufficient enzymatic activity in the digestive tract is ensured even when the pH range fluctuates as the result of varying feed components.
These objects are achieved by a synthetic phytase which has an amino acid sequence with at least 85% identity to the amino acid sequence of SEQ ID 24. These phytases according to the invention have a thermostability of at least 80° C. and are therefore suitable for being employed in the preparation of feed pellets without suffering a considerable activity loss as the result of the hot and moist conditions during pelleting.
They furthermore have a broad pH range of over 3 pH units, within which they retain at least 50% of the activity determined at pH 5.5, so that, when the dosage is determined on the basis of the activity at 5.5, they can be employed in a multiplicity of animals with different digestive pH and together with different feed components, without an unduly low dosage resulting in activity losses and therefore to an increased excretion of the phosphate by the animals.
Furthermore, the phytase according to the invention surprisingly have an elevated proteolytic stability, and therefore they can pass through the stomach without substantial activity losses and the activity at the actual site of action, in the gut, is retained. Furthermore, the phytases according to the invention have a stability at pH 2 of at least 85% and thus ensure only small activity losses in the highly acidic range.
The synthetic phytase can also have an amino acid sequence with at least 90% identity to the amino acid sequence of SEQ ID 24.
Preferably, the synthetic phytase according to the invention has an amino acid sequence with at least 94%, in particular by preference 95% and preferably 96, 97, 98 or 99% identity to the amino acid sequence of SEQ ID 24.
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-001 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-002 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-003 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-004 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-005 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-006 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-007 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-008 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-009 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-010 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-011 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-012 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-013 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-014 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-015 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-016 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-017 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-018 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-019 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-020 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-021 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-022 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-023 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-024 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-025 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-026 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-027 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-028 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-029 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-030 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-031 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-032 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-033 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-034 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-035 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-036 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-037 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-038 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-039 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-040 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-041 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-042 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-043 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-044 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-045 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-046 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-047 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-048 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-049 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-050 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-051 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-052 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-053 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-054 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-055 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-056 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-057 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-058 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-059 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-060 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-061 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-062 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-063 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-064 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-065 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-066 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-067 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-068 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-069 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-070 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-071 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-072 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-073 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-074 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-075 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-076 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-077 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-078 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-079 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-080 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-081 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-082 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-083 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-084 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-085 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-086 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-087 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-088 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-089 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-090 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-091 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-092 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-093 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-094 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-095 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-096 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-097 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-098 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-099 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-100 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-101 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-102 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-103 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-104 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-1105 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-106 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-107 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-109 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-110 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-111 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-112 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-113 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-114 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-115 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-116 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-117 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-118 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-119 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-120 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-121 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-122 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-123 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-124 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-125 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-126 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-127 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-128 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-129 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-130 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-131 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-132 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-133 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-134 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-135 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-136 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-137 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-138 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-139 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-140 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-141 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-142 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-143 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-144 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-145 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-146 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The object is furthermore achieved by a synthetic phytase which has an amino acid sequence with at least 95%, by preference 96%, preferably 97, 98 or 99%, identity to the amino acid sequence of the mutant PhV-147 (see Table 1, mutations as per column 2 based on SEQ ID 24).
The identity between two protein sequences or nucleic acid sequences is defined as the identity calculated by the program needle in the version available in April 2011. Needle is part of the freely available program package EMBOSS, which can be downloaded from the website http://emboss.sourceforge.net/. The standard parameters are used: gapopen 10.0 (“gap open penalty”), gapextend 0.5 (“gap extension penalty”), datafile EBLOSUM62 (matrix) in the case of protein and datafile EDNAFULL (matrix) in the case of DNA.
In one embodiment, the synthetic phytase has at least one conservative amino acid exchange at at least one position compared with one of the above-described phytases according to the invention:
For the purposes of the present invention, conservative means an exchange of the amino acid G to A; A to G, S; V to I, L, A, T, S; I to V, L, M; L to I, M, V; M to L, I, V; P to A, S, N; F to Y, W, H; Y to F, W, H; W to Y, F, H; R to K, E, D; K to R, E, D; H to Q, N, S; D to N, E, K, R, Q; E to Q, D, K, R, N; S to T, A; T to S, V, A; C to S, T, A; N to D, Q, H, S; Q to E, N, H, K, R. Here, it is possible to combine any conservative exchange of an amino acid with any conservative exchange of another amino acid as long as the phytase activity is retained.
Advantageously, the synthetic phytase is an isolated phytase. It is also feasible that the synthetic phytase is present not as a purified isolated phytase, but as a fermentation liquor, with the biomass being separated off fully, partially or not at all. Here, the liquor can be concentrated or dried fully by removing liquid. It is possible to employ these unpurified or partially purified phytase solutions or phytase solids as additive in different products.
The synthetic phytase according to the invention advantageously has an elevated stability to pepsin, an improved acid stability at pH 2, a widening of the active pH range and/or an elevated thermostability compared with the two wild-type phytases from the organisms Yersinia mollaretii and Hafnia sp., which were the basis of the construction of the synthetic phytase construct of SEQ ID 18.
The invention also comprises an isolated nucleic acid sequence coding for a phytase with an amino acid sequence with at least 81%, advantageously 85 or 90%, especially preferably 94% and in particular 95, 96, 97, 98 or 99%, identity to the amino acid sequence of SEQ ID 24.
The invention likewise comprises an isolated nucleic acid sequence which codes for an enzyme with phytase activity, where the nucleic acid sequence has at least 85% identity to the nucleic acid sequence of SEQ ID 25, or a nucleic acid sequence which hybridizes under highly-stringent conditions with the complementary strand of one of the abovementioned sequences with at least 85% identity to the nucleic acid sequence of SEQ ID 25. In a particular embodiment, the isolated nucleic acid sequence has more than 90%, in particular at least 91, 92, 93, 94, 95, 96, 97, 98 or 99%, identity to SEQ ID 25.
The invention furthermore comprises a recombinant expression vector comprising one of the nucleic acid sequences according to the invention.
The invention likewise comprises a recombinant host cell comprising one of the nucleic acids according to the invention or comprising the recombinant expression vector according to the invention.
The object is furthermore achieved by a recombinant production organism, which is a nonhuman production organism which comprises one of the nucleic acid sequences according to the invention or which comprises the recombinant expression vector according to the invention. The recombinant production organism is especially preferably one from the genus Aspergillus, Pichia, Trichoderma, Hansenula, Saccharomyces, Bacillus, Escherischia, Kluyveromyces, Schizosaccharomyces.
The invention furthermore comprises an animal feed additive which comprises at least one of the phytases according to the invention, in particular with an amino acid sequence corresponding to SEQ ID 24 or one of the mutants PhV-001, PhV-002, PhV-003, PhV-004, PhV-005, PhV-006, PhV-007, PhV-008, PhV-009, PhV-010, PhV-011, PhV-012, PhV-013, PhV-014, PhV-015, PhV-016, PhV-017, PhV-018, PhV-019, PhV-020, PhV-021, PhV-022, PhV-023, PhV-024, PhV-025, PhV-026, PhV-027, PhV-028, PhV-029, PhV-030, PhV-031, PhV-032, PhV-033, PhV-034, PhV-035, PhV-036, PhV-037, PhV-038, PhV-039, PhV-040, PhV-041, PhV-042, PhV-043, PhV-044, PhV-045, PhV-046, PhV-047, PhV-048, PhV-049, PhV-050, PhV-051, PhV-052, PhV-053, PhV-054, PhV-055, PhV-056, PhV-057, PhV-058, PhV-059, PhV-060, PhV-061, PhV-062, PhV-063, PhV-064, PhV-065, PhV-066, PhV-067, PhV-068, PhV-069, PhV-070, PhV-071, PhV-072, PhV-073, PhV-074, PhV-075, PhV-076, PhV-077, PhV-078, PhV-079, PhV-080, PhV-081, PhV-082, PhV-083, PhV-084, PhV-085, PhV-086, PhV-087, PhV-088, PhV-089, PhV-090, PhV-091, PhV-092, PhV-093, PhV-094, PhV-095, PhV-096, PhV-097, PhV-098, PhV-099, PhV-100, PhV-101, PhV-102, PhV-103, PhV-104, PhV-105, PhV-106, PhV-107, PhV-109, PhV-110, PhV-111, PhV-112, PhV-113, PhV-114, PhV-115, PhV-116, PhV-117, PhV-118, PhV-119, PhV-120, PhV-121, PhV-122, PhV-123, PhV-124, PhV-125, PhV-126, PhV-127, PhV-128, PhV-129, PhV-130, PhV-131, PhV-132, PhV-133, PhV-134, PhV-135, PhV-136, PhV-137, PhV-138, PhV-139, PhV-140, PhV-141, PhV-142, PhV-143, PhV-144, PhV-145, PhV-146 or PhV-147 (according to the definition in Table 1) or with an amino acid sequence with at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% identity thereto, and furthermore customary feed additives, for example for cattle, poultry or pigs, such as, for example, vitamins, minerals or other additives.
The invention furthermore comprises an animal feed which comprises at least one of the described synthetic phytases according to the invention, in particular with an amino acid sequence corresponding to SEQ ID 24 or one of the mutants PhV-001, PhV-002, PhV-003, PhV-004, PhV-005, PhV-006, PhV-007, PhV-008, PhV-009, PhV-010, PhV-011, PhV-012, PhV-013, PhV-014, PhV-015, PhV-016, PhV-017, PhV-018, PhV-019, PhV-020, PhV-021, PhV-022, PhV-023, PhV-024, PhV-025, PhV-026, PhV-027, PhV-028, PhV-029, PhV-030, PhV-031, PhV-032, PhV-033, PhV-034, PhV-035, PhV-036, PhV-037, PhV-038, PhV-039, PhV-040, PhV-041, PhV-042, PhV-043, PhV-044, PhV-045, PhV-046, PhV-047, PhV-048, PhV-049, PhV-050, PhV-051, PhV-052, PhV-053, PhV-054, PhV-055, PhV-056, PhV-057, PhV-058, PhV-059, PhV-060, PhV-061, PhV-062, PhV-063, PhV-064, PhV-065, PhV-066, PhV-067, PhV-068, PhV-069, PhV-070, PhV-071, PhV-072, PhV-073, PhV-074, PhV-075, PhV-076, PhV-077, PhV-078, PhV-079, PhV-080, PhV-081, PhV-082, PhV-083, PhV-084, PhV-085, PhV-086, PhV-087, PhV-088, PhV-089, PhV-090, PhV-091, PhV-092, PhV-093, PhV-094, PhV-095, PhV-096, PhV-097, PhV-098, PhV-099, PhV-100, PhV-101, PhV-102, PhV-103, PhV-104, PhV-105, PhV-106, PhV-107, PhV-109, PhV-110, PhV-111, PhV-112, PhV-113, PhV-114, PhV-115, PhV-116, PhV-117, PhV-118, PhV-119, PhV-120, PhV-121, PhV-122, PhV-123, PhV-124, PhV-125, PhV-126, PhV-127, PhV-128, PhV-129, PhV-130, PhV-131, PhV-132, PhV-133, PhV-134, PhV-135, PhV-136, PhV-137, PhV-138, PhV-139, PhV-140, PhV-141, PhV-142, PhV-143, PhV-144, PhV-145, PhV-146 or PhV-147 (according to the definition in Table 1) or with an amino acid sequence with at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% identity thereto, together with customary feed components. Feasible feed components in this context are all those which are conventionally employed in feed pellets for beef, dairy cow, poultry or pig fattening.
The invention furthermore comprises the use of one of the described synthetic phytases according to the invention, in particular with an amino acid sequence corresponding to SEQ ID 24 or one of the mutants PhV-001, PhV-002, PhV-003, PhV-004, PhV-005, PhV-006, PhV-007, PhV-008, PhV-009, PhV-010, PhV-011, PhV-012, PhV-013, PhV-014, PhV-015, PhV-016, PhV-017, PhV-018, PhV-019, PhV-020, PhV-021, PhV-022, PhV-023, PhV-024, PhV-025, PhV-026, PhV-027, PhV-028, PhV-029, PhV-030, PhV-031, PhV-032, PhV-033, PhV-034, PhV-035, PhV-036, PhV-037, PhV-038, PhV-039, PhV-040, PhV-041, PhV-042, PhV-043, PhV-044, PhV-045, PhV-046, PhV-047, PhV-048, PhV-049, PhV-050, PhV-051, PhV-052, PhV-053, PhV-054, PhV-055, PhV-056, PhV-057, PhV-058, PhV-059, PhV-060, PhV-061, PhV-062, PhV-063, PhV-064, PhV-065, PhV-066, PhV-067, PhV-068, PhV-069, PhV-070, PhV-071, PhV-072, PhV-073, PhV-074, PhV-075, PhV-076, PhV-077, PhV-078, PhV-079, PhV-080, PhV-081, PhV-082, PhV-083, PhV-084, PhV-085, PhV-086, PhV-087, PhV-088, PhV-089, PhV-090, PhV-091, PhV-092, PhV-093, PhV-094, PhV-095, PhV-096, PhV-097, PhV-098, PhV-099, PhV-100, PhV-101, PhV-102, PhV-103, PhV-104, PhV-105, PhV-106, PhV-107, PhV-109, PhV-110, PhV-111, PhV-112, PhV-113, PhV-114, PhV-115, PhV-116, PhV-117, PhV-118, PhV-119, PhV-120, PhV-121, PhV-122, PhV-123, PhV-124, PhV-125, PhV-126, PhV-127, PhV-128, PhV-129, PhV-130, PhV-131, PhV-132, PhV-133, PhV-134, PhV-135, PhV-136, PhV-137, PhV-138, PhV-139, PhV-140, PhV-141, PhV-142, PhV-143, PhV-144, PhV-145, PhV-146 or PhV-147 (according to the definition in Table 1) or with an amino acid sequence with at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% identity thereto, or of the animal feed additive according to the invention comprising at least one of the synthetic phytases according to the invention, in particular with an amino acid sequence corresponding to SEQ ID 24 or one of the mutants PhV-001, PhV-002, PhV-003, PhV-004, PhV-005, PhV-006, PhV-007, PhV-008, PhV-009, PhV-010, PhV-011, PhV-012, PhV-013, PhV-014, PhV-015, PhV-016, PhV-017, PhV-018, PhV-019, PhV-020, PhV-021, PhV-022, PhV-023, PhV-024, PhV-025, PhV-026, PhV-027, PhV-028, PhV-029, PhV-030, PhV-031, PhV-032, PhV-033, PhV-034, PhV-035, PhV-036, PhV-037, PhV-038, PhV-039, PhV-040, PhV-041, PhV-042, PhV-043, PhV-044, PhV-045, PhV-046, PhV-047, PhV-048, PhV-049, PhV-050, PhV-051, PhV-052, PhV-053, PhV-054, PhV-055, PhV-056, PhV-057, PhV-058, PhV-059, PhV-060, PhV-061, PhV-062, PhV-063, PhV-064, PhV-065, PhV-066, PhV-067, PhV-068, PhV-069, PhV-070, PhV-071, PhV-072, PhV-073, PhV-074, PhV-075, PhV-076, PhV-077, PhV-078, PhV-079, PhV-080, PhV-081, PhV-082, PhV-083, PhV-084, PhV-085, PhV-086, PhV-087, PhV-088, PhV-089, PhV-090, PhV-091, PhV-092, PhV-093, PhV-094, PhV-095, PhV-096, PhV-097, PhV-098, PhV-099, PhV-100, PhV-101, PhV-102, PhV-103, PhV-104, PhV-105, PhV-106, PhV-107, PhV-109, PhV-110, PhV-111, PhV-112, PhV-113, PhV-114, PhV-115, PhV-116, PhV-117, PhV-118, PhV-119, PhV-120, PhV-121, PhV-122, PhV-123, PhV-124, PhV-125, PhV-126, PhV-127, PhV-128, PhV-129, PhV-130, PhV-131, PhV-132, PhV-133, PhV-134, PhV-135, PhV-136, PhV-137, PhV-138, PhV-139, PhV-140, PhV-141, PhV-142, PhV-143, PhV-144, PhV-145, PhV-146 or PhV-147 (according to the definition in Table 1) or with an amino acid sequence with at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% identity thereto, in an animal feed. In this context, the use may take place in the form of the addition of the phytase according to the invention or of the animal feed additive according to the invention before the pelleting of the remaining feed components. It is also feasible to apply the phytase to these pellets after the preparation of feed pellets, in particular in liquid form.
The invention is furthermore achieved by the use of one of the above-described synthetic phytases according to the invention, in particular with an amino acid sequence corresponding to SEQ ID 24 or one of the mutants PhV-001, PhV-002, PhV-003, PhV-004, PhV-005, PhV-006, PhV-007, PhV-008, PhV-009, PhV-010, PhV-011, PhV-012, PhV-013, PhV-014, PhV-015, PhV-016, PhV-017, PhV-018, PhV-019, PhV-020, PhV-021, PhV-022, PhV-023, PhV-024, PhV-025, PhV-026, PhV-027, PhV-028, PhV-029, PhV-030, PhV-031, PhV-032, PhV-033, PhV-034, PhV-035, PhV-036, PhV-037, PhV-038, PhV-039, PhV-040, PhV-041, PhV-042, PhV-043, PhV-044, PhV-045, PhV-046, PhV-047, PhV-048, PhV-049, PhV-050, PhV-051, PhV-052, PhV-053, PhV-054, PhV-055, PhV-056, PhV-057, PhV-058, PhV-059, PhV-060, PhV-061, PhV-062, PhV-063, PhV-064, PhV-065, PhV-066, PhV-067, PhV-068, PhV-069, PhV-070, PhV-071, PhV-072, PhV-073, PhV-074, PhV-075, PhV-076, PhV-077, PhV-078, PhV-079, PhV-080, PhV-081, PhV-082, PhV-083, PhV-084, PhV-085, PhV-086, PhV-087, PhV-088, PhV-089, PhV-090, PhV-091, PhV-092, PhV-093, PhV-094, PhV-095, PhV-096, PhV-097, PhV-098, PhV-099, PhV-100, PhV-101, PhV-102, PhV-103, PhV-104, PhV-105, PhV-106, PhV-107, PhV-109, PhV-110, PhV-111, PhV-112, PhV-113, PhV-114, PhV-115, PhV-116, PhV-117, PhV-118, PhV-119, PhV-120, PhV-121, PhV-122, PhV-123, PhV-124, PhV-125, PhV-126, PhV-127, PhV-128, PhV-129, PhV-130, PhV-131, PhV-132, PhV-133, PhV-134, PhV-135, PhV-136, PhV-137, PhV-138, PhV-139, PhV-140, PhV-141, PhV-142, PhV-143, PhV-144, PhV-145, PhV-146 or PhV-147 (according to the definition in Table 1) or with an amino acid sequence with at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% identity thereto, of the animal feed additive according to the invention, which comprises at least one of the synthetic phytases according to the invention, in particular with an amino acid sequence corresponding to SEQ ID 24 or one of the mutants PhV-001, PhV-002, PhV-003, PhV-004, PhV-005, PhV-006, PhV-007, PhV-008, PhV-009, PhV-010, PhV-011, PhV-012, PhV-013, PhV-014, PhV-015, PhV-016, PhV-017, PhV-018, PhV-019, PhV-020, PhV-021, PhV-022, PhV-023, PhV-024, PhV-025, PhV-026, PhV-027, PhV-028, PhV-029, PhV-030, PhV-031, PhV-032, PhV-033, PhV-034, PhV-035, PhV-036, PhV-037, PhV-038, PhV-039, PhV-040, PhV-041, PhV-042, PhV-043, PhV-044, PhV-045, PhV-046, PhV-047, PhV-048, PhV-049, PhV-050, PhV-051, PhV-052, PhV-053, PhV-054, PhV-055, PhV-056, PhV-057, PhV-058, PhV-059, PhV-060, PhV-061, PhV-062, PhV-063, PhV-064, PhV-065, PhV-066, PhV-067, PhV-068, PhV-069, PhV-070, PhV-071, PhV-072, PhV-073, PhV-074, PhV-075, PhV-076, PhV-077, PhV-078, PhV-079, PhV-080, PhV-081, PhV-082, PhV-083, PhV-084, PhV-085, PhV-086, PhV-087, PhV-088, PhV-089, PhV-090, PhV-091, PhV-092, PhV-093, PhV-094, PhV-095, PhV-096, PhV-097, PhV-098, PhV-099, PhV-100, PhV-101, PhV-102, PhV-103, PhV-104, PhV-105, PhV-106, PhV-107, PhV-109, PhV-110, PhV-111, PhV-112, PhV-113, PhV-114, PhV-115, PhV-116, PhV-117, PhV-118, PhV-119, PhV-120, PhV-121, PhV-122, PhV-123, PhV-124, PhV-125, PhV-126, PhV-127, PhV-128, PhV-129, PhV-130, PhV-131, PhV-132, PhV-133, PhV-134, PhV-135, PhV-136, PhV-137, PhV-138, PhV-139, PhV-140, PhV-141, PhV-142, PhV-143, PhV-144, PhV-145, PhV-146 or PhV-147 (according to the definition in Table 1) or with an amino acid sequence with at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% identity thereto, or of the animal feed which comprises at least one of the described synthetic phytases, in particular with an amino acid sequence corresponding to SEQ ID 24 or one of the mutants PhV-001, PhV-002, PhV-003, PhV-004, PhV-005, PhV-006, PhV-007, PhV-008, PhV-009, PhV-010, PhV-011, PhV-012, PhV-013, PhV-014, PhV-015, PhV-016, PhV-017, PhV-018, PhV-019, PhV-020, PhV-021, PhV-022, PhV-023, PhV-024, PhV-025, PhV-026, PhV-027, PhV-028, PhV-029, PhV-030, PhV-031, PhV-032, PhV-033, PhV-034, PhV-035, PhV-036, PhV-037, PhV-038, PhV-039, PhV-040, PhV-041, PhV-042, PhV-043, PhV-044, PhV-045, PhV-046, PhV-047, PhV-048, PhV-049, PhV-050, PhV-051, PhV-052, PhV-053, PhV-054, PhV-055, PhV-056, PhV-057, PhV-058, PhV-059, PhV-060, PhV-061, PhV-062, PhV-063, PhV-064, PhV-065, PhV-066, PhV-067, PhV-068, PhV-069, PhV-070, PhV-071, PhV-072, PhV-073, PhV-074, PhV-075, PhV-076, PhV-077, PhV-078, PhV-079, PhV-080, PhV-081, PhV-082, PhV-083, PhV-084, PhV-085, PhV-086, PhV-087, PhV-088, PhV-089, PhV-090, PhV-091, PhV-092, PhV-093, PhV-094, PhV-095, PhV-096, PhV-097, PhV-098, PhV-099, PhV-100, PhV-101, PhV-102, PhV-103, PhV-104, PhV-105, PhV-106, PhV-107, PhV-109, PhV-110, PhV-111, PhV-112, PhV-113, PhV-114, PhV-115, PhV-116, PhV-117, PhV-118, PhV-119, PhV-120, PhV-121, PhV-122, PhV-123, PhV-124, PhV-125, PhV-126, PhV-127, PhV-128, PhV-129, PhV-130, PhV-131, PhV-132, PhV-133, PhV-134, PhV-135, PhV-136, PhV-137, PhV-138, PhV-139, PhV-140, PhV-141, PhV-142, PhV-143, PhV-144, PhV-145, PhV-146 or PhV-147 (according to the definition in Table 1) or with an amino acid sequence with at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% identity thereto, for reducing the phosphate content in the slurry of livestock.
The embodiments described are intended to illustrate and to give a better understanding of the invention and are in no way to be construed as limiting. Further features of the invention result from the description hereinbelow of preferred embodiments in conjunction with the dependent claims. In this context, the individual features of the invention may, in one embodiment, be realized in each case individually or together and are no limitation whatsoever of the invention to the described embodiment. The wording of the patent claims is hereby expressly made subject matter of the description.
Phytases are searched for in a series of enterobacteria analogously to the publications Huang et al. (2006) A novel phytase with preferable characteristics from Yersinia intermedia. Biochem Biophys Res Commun 350: 884-889, Shi et al. (2008) A novel phytase gene appA from Buttiauxella sp. GC21 isolated from grass carp intestine. Aquaculture 275:70-75 und WO2008116878 (Example 1) with the aid of the degenerate oligos Haf1090 5′-GAYCCNYTNTTYCAYCC-3′ (SEQ ID: 1) and Haf1092 5′-GGNGTRTTRTCNGGYTG-3′ (SEQ ID: 2) at annealing temperatures of between 40° C. and 50° C., using PCR. The PCR products formed are employed as template for a semi-nested PCR using the oligos Haf1090 5′-GAYCCNYTNTTYCAYCC-3′ (SEQ ID 1) and Haf1091 5′-GCDATRTTNGTRTCRTG-3′ (SEQ ID 3) under identical annealing conditions. A fragment can be isolated from a bacterial strain of the genus Hafnia (Hafnia sp. LU11047). The isolated fragment is subcloned with the aid of the “TOPO TA Cloning® Kit” (Invitrogen) following the manufacturer's instructions and subsequently sequenced. Starting from this part-sequence, the full-length sequence of the phytase is amplified via the so-called TAIL-PCR method (Yao-Guang Liu and Robert F. Whittier (1995) Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking. Genomics 25, 674-681). The following oligonucleotides are used for this purpose:
The DNA fragments obtained are cloned with the aid of the “TOPO TA Cloning® Kit” (Invitrogen) and sequenced. The nucleotide sequences give the gene SEQ ID 12, which codes for the Hafnia sp. LU11047 phytase. The amino acid sequence SEQ ID 13, which is derived therefrom, has 98% identity with the phytase sequence of a Hafnia alvei phytase from WO200811678. Using the software SignalP 2.0, the amino acids 1-33 are predicted to be a signal peptide. The mature enzyme, accordingly, starts with the serine in position 34.
1. Synthetic Phytase Fus5#2
Cloning the Phytase Fus5#2
Starting from the chromosomal DNA from Hafnia sp. LU11047, a fragment of base 1-1074 of the phytase (SEQ ID 14) is amplified by means of PCR. Oligonucleotides are derived from the DNA sequence of a putative phytase (or acidic phosphatase) from Yersinia mollaretii ATCC43969, NCBI Sequenz ID ZP—00824387 for amplifying the nucleotides 1057-1323. This is used to amplify a second phytase fragment from the chromosomal DNA from Yersinia mollaretii ATCC 43969 (SEQ ID 15). Upon amplification of the two phytase fragments, an overlap of 20 bp to the respective other phytase fragment is generated, with the aid of the oligos used, both at the 3′ end of the Hafnia fragment and at the 5′ end of the Yersinia fragment. In this manner, the two fragments can be combined via PCR fusion to give the phytase sequence SEQ ID 16, which codes for the synthetic phytase Fus5#2. For the amino acid sequence SEQ ID 17 derived therefrom, the amino acids 1-33 are predicted by the software SignalP 2.0 to be a signal peptide. The mature phytase Fus5#2 (SEQ ID 18) is encoded by the nucleotide sequence SEQ ID 19.
To clone an expression plasmid for E. coli, an NdeI restriction cleavage site is generated at the 5′ end of the phytase DNA fragment SEQ ID 16 and a HindIII restriction cleavage site and a stop codon are generated at the 3′ end. The sequences additionally required for this are introduced by means of a PCR reaction via the primers used, with the aid of the phytase SEQ ID 16 as the template. Using these cleavage sites, the phytase-encoding gene is cloned into the E. coli expression vector pET22b (Novagen). By using the NdeI restriction cleavage site and by introducing the stop codon, the pelB signal sequence is removed from the vector and read-through into the 6×His tag, which is present on the plasmid, is prevented. The plasmid pFus5#2 (SEQ ID 20) thus generated is transformed into the E. coli strain BL21(DE3) (Invitrogen). For the improved purification of the phytase protein, a phytase variant with an N-terminal 6×His tag is cloned. Using the sense oligo primerH6: 5′-ctatggatccgcatcatcatcatcatcacagtgataccgcccctgc-3′ (SEQ ID 21), which introduces not only the 6×His tag, but also a BamHI cleavage site, and which acts as a template for the sequence SEQ ID 19, which codes for the mature phytase protein, a PCR product is amplified. At the 3′ end of the PCR product, a stop codon and an NdeI restriction cleavage site are, again, introduced using the same antisense oligo. The fragment thus generated is cloned into the vector pET22b via BamHI/NdeI, giving rise to the plasmid pH6-Fus5#2 (SEQ ID 22), which is likewise transformed into E. coli BL21(DE3). In the case of this construct, the pelB signal sequence, which is comprised in pET22b, is used for the transport into the periplasma.
The phytase activity is determined in microtiter plates. The enzyme sample is diluted in reaction buffer (250 mM Na acetate, 1 mM CaCl2, 0.01% Tween 20, pH 5.5). 10 μl of the enzyme solution are incubated with 140 μl substrate solution (6 mM Na phytate (Sigma P3168) in reaction buffer) for 1 h at 37° C. The reaction is quenched by adding 150 μl of trichloroacetic acid solution (15% w/w). To detect the liberated phosphate, 20 μl of the quenched reaction solution are treated with 280 μl of freshly made-up color reagent (60 mM L-ascorbic acid (Sigma A7506), 2.2 mM ammonium molybdate tetrahydrate, 325 mM H2SO4), and incubated for 25 min at 50° C., and the absorption at 820 nm was subsequently determined. For the blank value, the substrate buffer on its own is incubated at 37° C. and the 10 μl of enzyme sample are only added after quenching with trichloroacetic acid. The color reaction is performed analogously to the remaining measurements. The amount of liberated phosphate is determined via a calibration curve of the color reaction with a phosphate solution of known concentration.
Expression in Escherichia coli
The E. coli BL21(DE3) strains, which harbor a plasmid with a phytase expression cassette, are grown at 37° C. in LB medium supplemented with ampicillin (100 mg/l). The phytase expression is induced at an OD (600 nm) of 0.6 by adding 1 mM IPTG. After 4 h of induction, 10% (v/v) of a 10× BugBuster solution (Novogen) is added and the mixture is incubated for 15 min at room temperature. After the centrifugation, the supernatant is used for determining the phytase activity.
To purify the 6×His-labeled phytase variants, an induced, phytase-expressing E. coli culture broth is treated with 300 mM NaCl, Complete™ Protease Inhibitor without EDTA (following the instructions of the manufacturer Roche Applied Science) and with 10% (v/v) of a 10× BugBuster solution (Novogen), and the mixture is incubated for 15 min at room temperature. After the centrifugation, the supernatant is bound to Ni-NTA columns/KIT (Qiagen) following the manufacturer's instructions. The elution after the wash steps is performed using cold elution buffer (50 mM Na acetate buffer, 300 mM NaCl, 500 mM imidazole, 1 mM CaCl2). Before determining the protein content, the sample is subjected to a buffer exchange for 2 mM sodium citrate pH 5.5 by dialysis.
Expression in Aspergillus niger
To express the phytase Fus5#2 in Aspergillus niger, an expression construct is first prepared which comprises the phytase gene under the control of the A. niger glucoamylase (glaA) promoter, flanked by the noncoding 3′-glaA region. In this manner, the construct is intended for integration into the 3′-glaA region in A. niger. The signal sequence used for the extracellular protein secretion is the signal sequence of the A. ficuum phytase. The base used for the expression construct is the Plasmid pGBGLA-53 (also referred to as pGBTOPFYT-1 in WO9846772), which is described in detail in EP0635574B1. With the aid of PCR-based cloning techniques known to a person skilled in the art, the gene segment of the A. ficuum phytase, which codes for the mature phytase protein starting with the amino acid sequence ASRNQSS, in pGBGLA-53 is replaced by the gene segment SEQ ID 19, which codes for the mature Fus5#2 phytase. This gives rise to the resulting plasmid pGLA53-Fus5#2 (SEQ ID 23). The cotransformation of the linear expression cassette, isolated from the resulting plasmid using HindIII, together with an amdS marker cassette, isolated from the plasmid pGBLA50 (EP0635574B1)/pGBAAS-1 (name of the same plasmid in WO9846772), into a glaA-deleted A. niger expression strain and the subsequent expression of the phytase in shake flasks is performed as described in the two cited patent specifications. The phytase activity in the culture supernatant is determined daily after the cells have been centrifuged off. The maximum activity is achieved between day 3 and day 6.
2. Phytase Variants of Phytase Fus5#2
Variants of the phytase are generated by mutating the gene sequence SEQ ID 19 by means of PCR. The “Quickchange Site-directed Mutagenesis Kit” (Stratagene) is used to carry out a directed mutagenesis. A random mutagenesis over the entire coding sequence, or else only part thereof, of SEQ ID 19 is performed with the aid of the “GeneMorph II Random Mutagenesis Kit” (Stratagene). The mutagenesis rate is set to the desired amount of 1-5 mutations via the amount of the template DNA used. Multiple mutations are generated by the targeted combination of individual mutations or by the sequential performance of several mutagenesis cycles.
The phytase variants generated are tested for phytase activity and thermostability in an assay with high-throughput capability. To this end, the E. coli BL21(DE3) clones obtained after the transformation with the pET22b-based expression construct are incubated (30° C., 900 rpm, shaker excursion 2 mm) in 96-well microtiter plates in LB Medium (2% glucose, 100 mg/l ampicillin). Induction is carried out with 1 mM IPTG for 4 h at an OD (600 nm) of approximately 0.5. Thereafter, 10% (v/v) of a 10× BugBuster solution (Novogen) is then added and the mixture is incubated for 15 min at room temperature. The phytase activity and the residual activity after 20 minutes of temperature stress are determined.
The phytase HF598 (SEQ ID 24) generated in this manner and variants thereof are cloned into the E. coli expression vector pET22b (Novagen) analogously to the procedures described in the previous section and subsequently expressed with the aid of the E. coli strain BL21(DE3). In addition, suitable expression constructs for Aspergillus niger are cloned so that the phytase can be expressed after transformation into A. niger. When using a synthetic gene (SEQ ID 25), which codes for the mature variant HF598 (SEQ ID 24) and which had been adapated to the codon usage of A. niger (GENEART AG, Regensburg), the plasmid pGla53-HF598 (SEQ ID 26) is obtained.
To record the thermal inactivation curve, the enzyme sample which is diluted in reaction buffer (250 mM Na acetate, 1 mM CaCl2, 0.01% Tween 20, pH 5.5) is heated for 20 min at the respective temperatures and thereafter cooled to 4° C. A reference sample which has not undergone thermal treatment is left at room temperature for 20 min and is then likewise cooled to 4° C. After the thermal pretreatment, the enzyme activity of the samples is determined by means of the phytase assay. The activity of the reference sample is normalized to 100%. The thermostability of the various phytase variants is characterized by what is known as the T50 value. The T50 indicates the temperature at which 50% residual activity is still present after thermal inactivation, compared with a reference sample which has not undergone thermal treatment. Changes in the thermostability of two phytase variants, expressed in ° C., result from the difference of the respective T50 values.
To determine the pH profile, a modified reaction buffer (100 mM Na acetate, 100 mM glycine, 100 mM imidazole, 1 mM CaCl2, 0.01% Tween 20), which is brought to pH values in the range of from pH 1.5-7 using dilute hydrochloric acid, is used for the phytase assay. To determine the relative activity, the activity measured at pH 5.5 is set at 100%. The results are shown in Tables 2 and 3.
To determine the stability at pH 2, the phytase sample is diluted in buffer (250 mM glycine, 3 mg/ml BSA, pH 2) to 30 U/ml. The sample is incubated for 30 min at 37° C. Thereafter, the sample is diluted directly with reaction buffer (250 mM Na acetate, 1 mM CaCl2, 0.01% Tween 20, pH 5.5) to the optimum measuring range of the phytase activity determination (approx. 0.6 U/ml), and the phytase activity is measured. By way of reference, the sample is incubated in parallel for 30 min at 37° C. in reaction buffer at a concentration of 30 U/ml, and the phytase activity is likewise analyzed. The activities of the pH-stressed samples are standardized to the reference value, which is set as 100% stability. Natuphos® (BASF) is likewise employed in the assay by way of comparison with a commercial phytase.
To determine the stability to pepsin, the phytase sample is diluted to 30 U/ml in pepsin-comprising buffer (250 mM glycine, 3 mg/ml BSA, pH 2, 10 mg/ml pepsin (Sigma P-7000, 445 U/mg). The sample is incubated for 30 min at 37° C. Thereafter, the sample is diluted directly with reaction buffer (250 mM Na acetate, 1 mM CaCl2, 0.01% Tween 20, pH 5.5) to the optimum measuring range of the phytase activity determination (approx. 0.6 U/ml), and the phytase activity is determined. By way of reference, the sample is incubated in parallel for 30 min at 37° C. in reaction buffer pH 5.5 at a concentration of 30 U/ml, and the phytase activity is likewise analyzed. The activities of the pepsin-treated samples are standardized to the reference value, which is set as 100% stability. Natuphos® (Natuphos® 10000L, BASF SE) was likewise employed in the assay by way of comparison with a commercial phytase.
| Number | Date | Country | Kind |
|---|---|---|---|
| 11163410.1 | Apr 2011 | EP | regional |
| Number | Date | Country | |
|---|---|---|---|
| 61477637 | Apr 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/IB12/51933 | Apr 2012 | US |
| Child | 13689958 | US |
